Next, we utilized isogenic models of breast cancer to explore how the presence or absence of RB led to changes in intrinsic cellular radiosensitivity and CDK4/6 inhibitor–mediated radiosensitization in ER+ and TNBC. This evidence concerns the gene RB1 and breast cancer.